Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Dec 22, 2019 5:31pm
147 Views
Post# 30481989

RE:RE:RE:RE:RE:WHEN IS THE LAST TIME, IF EVER, SOMEONE HAS CONTACTED '60

RE:RE:RE:RE:RE:WHEN IS THE LAST TIME, IF EVER, SOMEONE HAS CONTACTED '60Scorpio2 wrote

  So Laser...can we look at the 5 patients in Phase 2 and the 2 patients from Phase 1 (being patient #5 and #6) as comprising our statistically valid pool ? or are we going to need all 7 patients from Phase 2. I would assume that many will act (invest) on just the 7 (2+ 5) patients as it's statistically valid but we may need to have alll 7 ifrom Phase 2 for simple comparative purposes to Sesen's 7.

Scorpio2 .. LaserStock29 is correct however in my opinion the 7 patients (2+5) if 100% CR along with IND approval would be enough for shows such as local Toronto news stations interviews. BNN should by all rights be in my opinion the first to have media coverage with Theralase as you probably know back in 2014 they did an interview and just for that reason alone should be awarded a 2nd. BNN would need more then 7 patients 100%CR my guesstimate somewhere around 20 minimum all with 6 months results and where would that be time wise ...  fall of 2020? Don't forget even with patients reaching 6 months 100% it still can take any show months to broadcast as many tape weeks or months ahead.
Bullboard Posts